B
원바이오젠
307280KOSDAQ의료용품 및 기타 의약 관련제품 제조업66.0 / 100
Reference Date: 2026-04-13
Financial Score31.5 / 40
News Sentiment12.5 / 25
Momentum12.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health and PER is significantly undervalued vs. peers is also solid. Slightly down 2.9% over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
Wonbiogen is a wound care dressing manufacturer specializing in foam and hydrocolloid dressings, supplying hospitals, pharmacies, and OTC markets. Market growth is driven by expanded health insurance coverage, aging population, changing perceptions of wound care, and increasing demand for aesthetic purposes.
Number of Employees
77people
Average Salary
0.1M KRW
Score Calculation Basis
Detailed Financial Score
PER
7.28Industry Average 19.898.0Point
Half of industry avg (excellent)
PBR
1.13Industry Average 1.625.5Point
Lower than industry avg (good)
ROE
16.17Industry Average -4.893.5Point
Well below industry avg
Debt Ratio
1.15Industry Average 8.888.0Point
Half of industry avg (excellent)
Trend 2023~20256.5 / 10 points
Revenue Growth Rate
2.0 / 3
Avg ▲9.3% (2-year basis)
Operating Profit Growth Rate
2.0 / 3
Avg ▲6.8% (2-year basis)
ROE Trend
2.5 / 4
Avg ROE 17.2% (declining, 3yr)
Detailed News Sentiment
1 totalPositive 0Neutral 0Negative 0
- Neutral
Detailed Momentum
52-week position5.0Point
52w mid range (56%)
Current 6,790Won52-week high 8,25052-week low 4,875
1-month return2.0Point
1m -2.86% (slight drop)
Volume trend5.0Point
Volume increasing
Detailed Disclosure
3 totalPositive 0Neutral 3Negative 0
- Neutral정기주주총회결과2026-03-31
- Neutral감사보고서제출2026-03-23
- Neutral사업보고서 (2025.12)2026-03-23